Key result
Preoperative metformin shows no association with higher lactate or impaired clearance after cardiac surgery.
Why the study?
Early discontinuation of metformin before cardiac surgery is recommended by several societies without hard supporting evidence, relying mostly on extrapolations from other clinical settings.
Does preoperative metformin use increase postoperative lactate concentrations or impair lactate clearance in patients undergoing elective on-pump cardiac surgery?
Observational (n=367)
No
Does preoperative metformin use increase postoperative lactate concentrations or impair lactate clearance in patients undergoing elective on-pump cardiac surgery?
p-value: p=0.53
Continuing metformin until the night before elective on-pump cardiac surgery does not increase postoperative lactate concentrations or impair lactate clearance, challenging current recommendations for early discontinuation.
May support continuing metformin until night before cardiac surgery; leaves open need for RCTs to confirm safety.
Aim. Early discontinuation of metformin before cardiac surgery is advised by several national societies but no hard evidence exist supporting this practice. This precaution is mostly extrapolated by data on different clinical settings. The aim of this study is to investigate the impact of preoperative metformin use on lactate concentrations and lactate clearance during the first postoperative day after cardiac surgery.Methods. Among 367 consecutive patients who underwent elective on-pump cardiac surgery from January 2019 to October 2019, 109 were diabetics, 74 of which were treated with metformin. Data on lactate concentrations and clearance during the first postoperative day were prospectively collected on arrival, H6, H12 and H24 in the ICU and compared. A subgroup analysis focusing only on diabetic patients was also performed. Repeated measures multivariate analysis of variance (MANOVA) was used to investigate the data based on group, time and their interaction effects.Results. Lactate concentrations were the same for both groups upon arrival in the ICU. Interestingly, metformin users had lower lactate concentrations than non-users on the following measurements (p = 0.003 at 6 h and p = 0.01 at 24 h). No significant interaction was found between the two groups (p = 0.76). No difference was found between the two groups in terms of lactate clearance (p = 0.53). In the subgroup analysis no difference was found between metformin users and non-users neither on lactate concentrations (p = 0.61) nor on lactate clearance (p = 0.86).Conclusions. In a post cardiac surgery ICU setting, using metformin up until the night before surgery was not associated with increased postoperative lactate concentrations or impaired lactate clearance.
No takes yet. Share an insight, caveat, or question.
Ampatzidou et al. (2022) conducted an observational in Elective on-pump cardiac surgery (n=367). Metformin vs. Non-metformin users was evaluated on Lactate clearance over 24 hours (p=0.53). Metformin use up until the night before elective cardiac surgery was not associated with increased postoperative lactate concentrations or impaired lactate clearance compared to non-users.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: